Heart Disease in Black Women: What You Need to Know About the Nation's Highest-Mortality Cardiovascular Gap

Heart disease is the leading cause of death in Black women in the United States. In the CARDIA cohort, 27 young adults developed heart failure before age 50 at a mean onset age of 39, and 26 of them were Black, per Bibbins-Domingo and colleagues, New England Journal of Medicine 2009 (PMID 19297571). The cumulative incidence before age 50 was 1.1 percent for Black women and 0.08 percent for white women, a 14-fold gap. Three-quarters of the Black participants who developed heart failure had clinical hypertension by age 40. This hub is our cornerstone synthesis on Black women and cardiovascular disease: what the evidence shows about the gap, why it starts so young, which warning signs warrant same-day clinical contact, what the ACE-vs-ARB medication choice evidence says, and the screening-age question that sits at the center of prevention. Supporting articles on heart failure, blood-pressure medication, the race-concordance evidence, and screening-age decision-making are linked inline.

The CARDIA cohort (Coronary Artery Risk Development in Young Adults) enrolled approximately 5,100 Black and white adults aged 18 to 30 at baseline in 1985-1986 and followed them over 20 years. The finding that 26 of 27 heart-failure cases before age 50 were Black participants is not an outlier; it is the downstream outcome of a decade of uncontrolled or under-treated hypertension. The Multi-Ethnic Study of Atherosclerosis reported heart failure incidence of 4.6 per 1,000 person-years in African American participants versus 2.4 in white participants, per the 2008 Archives of Internal Medicine analysis by Bahrami and colleagues (PMID 18955644). Crucially, the racial disparity lost statistical significance in MESA's models once they adjusted for hypertension and diabetes. The gap is not written into ethnicity; it is written into untreated blood pressure.

Our earlier reporting at /articles/heart-failure-black-patients-earlier-onset/ unpacks the CARDIA finding in depth, including the five-question framework patients should bring to a cardiology visit when ejection fraction is being discussed.

For Black women specifically, three additional layers compound the CARDIA-baseline risk. The American Heart Association's 2016 scientific statement on cardiovascular disease in Black women named hypertension, diabetes, obesity, and preeclampsia/pregnancy-hypertension history as the driving modifiable risk factors. Premature menopause, when it occurs earlier in Black women's lives per the SWAN Study, adds a cardiovascular-risk increment separately from the conventional risk factors. And the Hoffman 2016 PNAS literature on provider bias in pain management extends into cardiovascular care: Black women's chest pain is more likely to be dismissed or attributed to anxiety in emergency-department settings, and the presenting-symptom pattern for Black women with acute cardiovascular events frequently differs from the chest-pain-radiating-to-left-arm template most ER triage protocols use.

The CDC Pregnancy Mortality Surveillance System classifies roughly 4 of every 5 US maternal deaths as preventable. The same preventability pattern applies to cardiovascular events outside pregnancy. The symptoms that warrant same-day clinical contact and often immediate emergency-department evaluation:

Atypical chest presentation. Pressure, tightness, squeezing, or burning sensation in the chest, arm, jaw, back, or upper abdomen. Black women are more likely than white women to present with non-classical chest pain or with pain absent altogether, and more likely to have their symptoms attributed to indigestion or anxiety on first medical contact. The rule: a new chest sensation that lasts more than a few minutes and is not clearly explained by recent exercise or a meal warrants a same-day call, not a wait-and-see.

Shortness of breath at rest or with minimal exertion. New-onset shortness of breath, particularly lying flat at night or on brief stair-climbing, is a cardiac symptom until proven otherwise. It is particularly characteristic of heart-failure-with-preserved-ejection-fraction (HFpEF), which disproportionately affects Black women.

Unusual fatigue. Not end-of-a-long-week tired, but the kind of tired that makes familiar tasks feel unfamiliar. When paired with shortness of breath, this is a specific cardiac-symptom cluster.

Swelling in the legs or abdomen. Peripheral edema is a later-stage sign of heart failure. Same-day call.

Palpitations with other symptoms. Rapid or irregular heartbeat paired with lightheadedness, chest pressure, or shortness of breath warrants emergency evaluation. Atrial fibrillation is the most common sustained arrhythmia; Black patients receive catheter ablation treatment at 35 percent lower odds than white patients, per Nosair and colleagues, JACC Advances 2025 (PMID 40857826). The symptom deserves the same urgent evaluation regardless of the downstream-treatment disparity.

Fainting or near-fainting. Either is a cardiovascular red flag in any age group.

The CDC's Hear Her campaign lists the urgent pregnancy-related cardiovascular symptoms specifically for obstetric patients. For non-pregnant Black women, the symptoms above are the escalation list; pair them with a specific same-day clinical contact (your primary care clinician's same-day line, an urgent-care visit for milder new symptoms, or emergency services for the red flags).

For Black women with hypertension, the first-line medication question has a specific answer that depends on chronic kidney disease status. Our companion piece at /articles/ace-or-arb-black-patients-blood-pressure-medication-choice/ unpacks the full evidence. The short version:

Without CKD: JNC 8 Recommendation 5 supports thiazide-type diuretics or calcium channel blockers as first-line. ALLHAT's Black-subgroup finding (ALLHAT Officers and Coordinators, JAMA 2002, PMID 12479763) and Brown 1996's documented 4.5-fold Black-patient angioedema risk on ACE inhibitors together argue against ACE-first for Black women without CKD.

With CKD: JNC 8 Recommendation 6 and AASK's kidney-protective evidence support ACE inhibitors or ARBs as first-line. The AASK finding that ramipril produced a 22 percent reduction in the composite of kidney failure or death vs metoprolol (and 38 percent vs amlodipine) applies directly to Black CKD patients.

The eGFR reclassification under the 2021 NKF-ASN race-free equation (Delgado et al., JASN 2021, PMID 34556489) can move Black women from Recommendation 5 (thiazide or CCB first-line) to Recommendation 6 (ACE or ARB first-line) on a single lab-recalculation. Ask your clinician whether your most recent eGFR was calculated without race-adjustment.

The USPSTF 2022 statement on cardiovascular-risk screening recommends lipid-panel-based 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimation starting at age 40 for most adults, and at age 35 for adults with additional cardiovascular risk factors including hypertension, diabetes, obesity, or family history. For Black women specifically, the AHA 2016 Black-women scientific statement supports earlier and more-frequent screening given the CARDIA-documented baseline risk. The answer to "at what age should I start cardiovascular screening" for a Black woman with any of the standard risk factors is: at 35, not at 40. Our dedicated piece on the screening-age question is in the Factory 1 queue for publish this summer.

Blood pressure screening separately should happen at every primary-care visit from adolescence onward. Home monitoring is the evidence-based complement to clinic readings; the combination is more predictive of outcome than either alone. The target for most adults without CKD is under 130/80 per the 2017 ACC/AHA hypertension guideline. For Black women with CKD or diabetes, the target may be tighter; this is a question to bring to the primary care clinician or cardiologist visit.

The DASH eating pattern (Dietary Approaches to Stop Hypertension) lowers systolic blood pressure by roughly 5 to 11 mm Hg in clinical trials. The DASH-Sodium trial showed larger effects in Black participants than in white participants, with a systolic drop approaching 11.4 mm Hg on the DASH diet at the lowest sodium level. Our dedicated piece on the DASH diet's Black-subgroup evidence is in the Factory 1 queue. The short version: if you are eating on a budget and can make one change, reducing sodium (most processed foods, most restaurant meals, most canned soups) produces the fastest measurable effect.

Physical activity at 150 minutes per week of moderate-intensity (brisk walking counts) is the AHA baseline. For Black women with established cardiovascular disease, a cardiac rehabilitation program is the supervised structure; Black women are referred to cardiac rehab at lower rates than white women, which is a documented care-gap worth asking about directly after any cardiac event.

Smoking cessation produces the largest single cardiovascular-risk reduction of any lifestyle change. For Black women specifically, the evidence-based pharmacotherapy options (nicotine replacement, varenicline, bupropion) all work, and community-based programs including culturally-adapted CBT have been shown to improve quit rates.

A Black cardiologist is not a guarantee of better care, and a non-Black cardiologist can deliver excellent care. Our reporting at /articles/racial-concordance-replication-greenwood-borjas/ covers the contested mortality-outcome literature. What the evidence does support is that patient-clinician race concordance improves preventive-service uptake and care-satisfaction ratings. For cardiovascular care specifically, the Association of Black Cardiologists (abcardio.org) maintains a specialty directory of Black cardiologists with organization-verified membership; our own directory at /providers/ filters cardiologists by city and insurance. Our find-a-black-doctor piece covers the three-layer spine on what race concordance does and does not guarantee.

Dr. Michelle A. Albert, MD, MPH, is Professor of Medicine at UCSF Cardiology, holder of the Walter A. Haas-Lucie Stern Endowed Chair in Cardiology, Director of the UCSF NURTURE Center (Center for the stUdy of AdveRsiTy and CardiovascUlaR DiseasE), and the first Black woman to serve as AHA President. Her research program focuses on cumulative toxic stress and cardiovascular disease in Black women, including the NURTURE lifecycle-framework papers. Institution: UCSF Cardiology.

Dr. Keith C. Ferdinand, MD, is Professor of Medicine at Tulane University School of Medicine and a past President of the Association of Black Cardiologists. His research on Black-patient cardiovascular outcomes and the Jackson Heart Study is the clinical reference literature for Black cardiovascular care. Institution: Tulane.

Neither has been interviewed for this hub. The citations above are their published-record research under their respective institutional affiliations. For an on-the-record voice on a Black-women-specific cardiovascular case, Albert is the most directly on-topic available expert.

1. If you are a Black woman with any new cardiovascular symptom above, call your clinician same-day. If symptoms are severe, call 911. The symptom rules out cardiac cause; the wait-and-see rules do not.

2. Ask for your most recent blood pressure reading and your most recent lipid panel results. If you are over 35 and have not had either in the past year, schedule both. Home BP monitoring is the complement; a $30 upper-arm cuff and twice-daily readings over a week is a more-predictive record than any clinic reading.

3. If you are on an ACE inhibitor for hypertension without CKD, ask whether a thiazide-type diuretic or a calcium channel blocker would be the evidence-supported first-line for you. Reference: JNC 8 Recommendation 5 + the ACE/ARB companion piece linked above.

4. If your most recent eGFR was calculated with the pre-2021 race-adjusted equation, ask for a recalculation using the 2021 equation. A Black woman whose eGFR was reported as normal under the old equation may be reclassified into the CKD range under the new, which changes first-line medication choice.

5. Search the blackhealth.org directory for Black cardiologists in your city or check the Association of Black Cardiologists finder. Cardiology race-concordance is not a guarantee, but the preventive-care uptake evidence from Alsan 2019 Oakland RCT supports it as a preference-aligned choice.

We will update this hub as the supporting Factory 1 pieces (early-warning-signs-heart-disease-Black-women, best-diet-for-lowering-BP-naturally, at-what-age-should-Black-women-start-heart-screenings, statins-Black-patients) ship and link in, as the American Heart Association publishes new Black-women scientific statements, and as the find-a-Black-cardiologist Factory 3 piece (when added to calendar) ships.

Dr. Kendra Amari, DrPH, is Editor-in-Chief of blackhealth.org. This hub is a synthesis across our published cardiovascular reporting for Black women, updated as new supporting articles publish. Last reviewed 2026-04-24.

Supporting articles in this cluster: - Black adults develop heart failure at 39 on average, 20 years before white peers - ACE or ARB for Black patients: the trial evidence - A 2024 PNAS replication weakened the Greenwood concordance finding - How to find a Black doctor near you: what the data says - Early warning signs of heart disease in Black women (pitched 2026-06-18) - Best diet for lowering blood pressure naturally (pitched 2026-06-28) - At what age should Black women start heart screenings (pitched 2026-07-08) - Statins for Black patients: pravastatin vs atorvastatin (sprint 2)